AngioplastyThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

6156 records returned

Cangrelor not CHAMPION for PCI patientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Two CHAMPION trials show disappointing results for the novel fast-acting intravenous platelet inhibitor cangrelor before or after percutaneous coronary intervention, with no reduction in the rate of death, myocardial infarction, or revascularization at 48 hours compared with clopidogrel treatment. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - November 20, 2009 Category: Internal Medicine Source Type: news

Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower CostEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Researchers say medications provide the same amount of protection as angioplasty in treating type-2 diabetics, and new insight shows the choice could be a significant money saver. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - November 20, 2009 Category: Consumer Health News Source Type: news

Hospital seeks funds for angioplasty centreEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The foundation at one of Windsor's hospitals has begun soliciting funds from regional governments to help pay for a new, $12.5-million angioplasty centre. (Source: CBC | Health)
Source: CBC | Health - November 19, 2009 Category: Consumer Health News Source Type: news

Transfusion Tied to Mortality in STEMI Treated With Primary PCIEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Red blood cell transfusion is associated with increased mortality in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), researchers report in the European Heart Journal for November. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2009 Category: Consumer Health News Tags: Cardiology Source Type: news

Journal Scan: 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) (J Am Coll Cardiol 2009;Nov 18:[Epub ahead of print].)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Cardiosource)
Source: Cardiosource - November 19, 2009 Category: Cardiology Source Type: organizations

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
No abstract (Source: Catheterization and Cardiovascular Interventions)
Source: Catheterization and Cardiovascular Interventions - November 19, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Frederick G. Kushner, Mary Hand, Sidney C. Smith Jr, Spencer B. King III, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey Jr, Lee A. Green, Alice K. Jacobs, Judith S. Hochman, Harlan M. Krumho Source Type: journals

Initial medical rather than interventional management more cost-effective for most diabetic patients with stable CHDEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Circulation Area: News The most cost-effective initial treatment for diabetic patients with stable coronary heart disease (CHD) depends on the seriousness of their CHD: intensive medical management appears more cost-effective than percutaneous coronary intervention (PCI) in less seriously affected patients, however those with more severe disease should probably proceed straight to CABG (coronary artery bypass grafting). These conclusions come from pre-specified secondary outcome and economic analyses of the BARI-2D trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes), published early on...
Source: NeLM - Cardiovascular Medicine - November 19, 2009 Category: Cardiology Source Type: organizations

Focused update 2009 of ACC/AHA guidelines for management of ST-elevation myocardial infarction and percutaneous coronary interventionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Circulation Area: News In an effort to respond promptly to new evidence, the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) Task Force on Practice Guidelines has created a "focused update" process to revise the existing guideline recommendations that are affected by evolving data or opinion. These updated guideline recommendations reflect a consensus of expert opinion after a review primarily of late-breaking clinical trials identified as being important to the relevant patient population, as well as a review of other new data deemed to have an impact on patient care. A focused upd...
Source: NeLM - Cardiovascular Medicine - November 19, 2009 Category: Cardiology Source Type: organizations

New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCIEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 (HSMN NewsFeed) -- Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention ... Biopharmaceuticals, CardiologyEli Lilly, Effient, prasugrel, antiplatelet, STEMI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2009 Category: Pharmaceuticals Source Type: news

AHA: Prasugrel Incorporated into New STEMI Guidelines (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (MedPage Today) -- A 60-milligram loading dose of prasugrel (Effient) is now a recommended alternative to clopidogrel for patients with ST-elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention, according to updated guidelines. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 18, 2009 Category: Cardiology Source Type: news

An unusual primary percutaneous coronary interventionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Heart)
Source: Heart - November 18, 2009 Category: Cardiology Authors: Ezzat, V A, Holdright, D R Tags: Miscellanea Source Type: journals

Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging studyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: Myocardial injury during PCI or CABG, identified by DE-CMR, adversely affects clinical outcome. This suggests the benefits from revascularisation could partially be offset by new myocardial injury caused by the intervention itself. (Source: Heart)
Source: Heart - November 18, 2009 Category: Cardiology Authors: Rahimi, K, Banning, A P, Cheng, A S H, Pegg, T J, Karamitsos, T D, Channon, K M, Darby, S, Taggart, D P, Neubauer, S, Selvanayagam, J B Tags: Editor's choice, Drugs: cardiovascular system, Interventional cardiology, Acute coronary syndromes, Percutaneous intervention, Clinical diagnostic tests Original articles Source Type: journals

AHA: Beating Heart Bypass Better for Brain than PCI (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (MedPage Today) -- Percutaneous coronary intervention (PCI) may be worse for the brain than coronary artery bypass grafting (CABG) without the heart-lung machine, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 18, 2009 Category: Cardiology Source Type: news

New Heart Attack Treatment Guidelines Stress CoordinationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Getting patients to the right hospitals quickly is critical, experts say Source: HealthDay Related MedlinePlus Topics: Angioplasty, Coronary Artery Disease, Heart Attack (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 18, 2009 Category: Consumer Health News Source Type: consumer

For Diabetic Patients With Heart Disease, Drug Therapy More Cost-Effective Than AngioplastyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. Previous research had shown that patients with type-2 diabetes and mild-to-moderate heart disease have no reduction in risk for heart attacks, strokes or death if they have an angioplasty compared with simply taking the right medications. (Source: Cardiovascular / Cardiology News From Medical News Today)
Source: Cardiovascular / Cardiology News From Medical News Today - November 18, 2009 Category: Cardiology Tags: Heart Disease Source Type: news

Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This study showed among STEMI patients treated with Gp IIb–IIIa inhibitors, that distal embolization is independently associated with impaired myocardial perfusion and survival. Content Type Journal ArticleDOI 10.1007/s11239-009-0419-yAuthors Giuseppe De Luca, “Maggiore della Carità” Hospital, Eastern Piedmont University Division of Cardiology Novara ItalyC. Michael Gibson, Brigham & Women’s Hospital TIMI Study Group, Cardiovascular Division Boston MA USAFrancesco Bellandi, Prato Hospital Division of Cardiology Prato ItalyMarko Noc, University Medical Center Center for Intensive Internal Medicine Ljubljana S...
Source: Journal of Thrombosis and Thrombolysis - November 18, 2009 Category: Hematology Tags: Journal of Thrombosis and Thrombolysis Source Type: journals

Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DESEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This study shows that among STEMI patients undergoing primary angioplasty with Gp IIb–IIIa inhibitors, diabetes is associated with worse long-term mortality, reinfarction, and IST, even with DES implantation, that, however, were able to equalize the outcome in terms of TVR as compared to non diabetic patients. Content Type Journal ArticleDOI 10.1007/s11239-009-0420-5Authors Giuseppe De Luca, Eastern Piedmont University Division of Cardiology, Ospedale “Maggiore della Carità” C.so Mazzini 18 28100 Novara ItalyRosario Sauro, “S.G. Moscati” Division of Cardiology Avellino ItalyAttilio Varricchio, “S.G. Mos...
Source: Journal of Thrombosis and Thrombolysis - November 18, 2009 Category: Hematology Tags: Journal of Thrombosis and Thrombolysis Source Type: journals

The relationship between reverse redistribution of 99mTc-tetrofosmin in sub-acute phase and left ventricular functional recovery in chronic phase in patients with acute myocardial infarctionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion These findings suggested that quantitative evaluation of RRD by gated 99mTc-tetrofosmin SPECT in the sub-acute phase can predict recovery of left ventricular function in the chronic phase with higher accuracy in patients with AMI who underwent direct PCI. Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12149-009-0318-5Authors Sei Fujiwara, Kobe University Graduate School of Medicine Division of Cardiovascular Medicine, Department of Internal Medicine 7-5-1 Kusunoki-cho, Chuo-ku Kobe Hyogo 650-0017 JapanHideyuki Shiotani, Kobe University Graduate School of Health Sciences Ko...
Source: Annals of Nuclear Medicine - November 17, 2009 Category: Radiology Tags: Annals of Nuclear Medicine Source Type: journals

Effects of Depressive Symptoms, Anxiety and Alexithymia on Physical Functioning 6 Months after Percutaneous Transluminal Coronary AngioplastyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Psychother Psychosom 2010;79:59-60 (DOI:10.1159/000259420) (Source: Karger Publishers)
Source: Karger Publishers - November 17, 2009 Category: Cancer & Oncology Source Type: journals

Drug Therapy More Cost-Effective Than Angioplasty for Diabetic Patients with Heart Disease, Stanford Researcher FindsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
STANFORD, Calif.--(BUSINESS WIRE)--Nov 17, 2009 - Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news

Primary PCI safe to perform with no on-site cardiac surgery supportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
There is no difference in mortality among patients with ST-elevation myocardial infarction who undergo primary angioplasty at hospitals where there is and where there is not cardiac surgery on-site (SOS), data from a registry-based study suggest. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - November 17, 2009 Category: Cardiology Source Type: news

Clinical Trial Summary: Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D — Presented at AHA 2009)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BARI 2D is a study of patients with type 2 diabetes with mild or stable cardiac symptoms designed to determine whether treatment targeted to attenuate insulin resistance can arrest or retard progression of coronary artery disease compared with treatment with an insulin-providing approach. It is also. . . (Source: Cardiosource)
Source: Cardiosource - November 17, 2009 Category: Cardiology Source Type: organizations

Stroke Incidence Related To Angioplasty Remains Steady Over Past 15 YearsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty remained steady over a 15-year period. Researchers say this is good news because physicians now are performing the artery-opening procedure on older patients who are sicker and need more complicated treatment. VIDEO ALERT: Additional audio and video resources, including comments by Dr. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2009 Category: Consumer Health News Tags: Stroke Source Type: news

Stroke Incidence Related To Angioplasty Remains Steady Over Past 15 YearsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty remained steady over a 15-year period. Researchers say this is good news because physicians now are performing the artery-opening procedure on older patients who are sicker and need more complicated treatment. (Source: Stroke / Neuroprotection News From Medical News Today)
Source: Stroke / Neuroprotection News From Medical News Today - November 17, 2009 Category: Neurology Tags: Stroke Source Type: news

Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateCategory: Health NewsCreated: 11/16/2009 12:10:00 PMLast Editorial Review: 11/17/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 17, 2009 Category: Cancer & Oncology Source Type: consumer

Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateCategory: Health NewsCreated: 11/16/2009 12:10:00 PMLast Editorial Review: 11/17/2009 (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - November 17, 2009 Category: Gastroenterology Source Type: consumer

Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateCategory: Health NewsCreated: 11/16/2009 12:10:00 PMLast Editorial Review: 11/17/2009 (Source: MedicineNet Senior Health General)
Source: MedicineNet Senior Health General - November 17, 2009 Category: Geriatrics Source Type: consumer

Drug therapy more cost-effective than angioplasty for diabetic patients with heart diseaseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Stanford University Medical Center) Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2009 Category: Global & Universal Source Type: news

BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical SettingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
AstraZeneca announced results of a PLATO sub-analysis in the most serious type of Acute Coronary Syndrome (ACS) patients, those with ST Segment Elevation Myocardial Infarction (STEMI). In this setting, ST segment elevation indicates total obstruction of a coronary artery which warrants emergency surgery with angioplasty, (Source: World Pharma News)
Source: World Pharma News - November 17, 2009 Category: Pharmaceuticals Source Type: news

Ticagrelor shows better efficacy compared to clopidogrel in patients with STEMI and planned PCIEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Reuters Health News Area: News According to research presented at the American Heart Association Scientific Session, ticagrelor prevents cardiovascular (CV) events in very high risk patients (those with ST Segment Elevated Myocardial Infarction (STEMI) who require percutaneous coronary intervention (PCI)) with no increased risk of overall major bleeding compared to the current standard of treatment, clopidogrel. Researchers presented the results of the phase III PLATelet inhibition and patient Outcomes (PLATO study) which showed that compared to clopidogrel, treatment with ticagrelor resulted in a reduc...
Source: NeLM - Cardiovascular Medicine - November 17, 2009 Category: Cardiology Source Type: organizations

AHA: Proton Pump Inhibitors May Up Post-PCI MortalityEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In patients who undergo percutaneous coronary intervention with drug-eluting stents, use of proton pump inhibitors is associated with an increased risk of all-cause mortality, according to research presented this week at the American Heart Association Scientific Sessions, held from Nov. 14 to 18 in Orlando, Fla. (Source: Modern Medicine)
Source: Modern Medicine - November 17, 2009 Category: Journals (General) Source Type: info

AHA: Two Separate Studies Find Cangrelor Not SuperiorEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In patients undergoing percutaneous coronary intervention, the use of cangrelor is not superior to the use of clopidogrel or placebo, according to two studies published online Nov. 15 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions, held from Nov. 14 to 18 in Orlando, Fla. (Source: Modern Medicine)
Source: Modern Medicine - November 17, 2009 Category: Journals (General) Source Type: info

AHA: PCI Without Surgical Backup Appears Safe (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (MedPage Today) -- Patients with ST-elevation myocardial infarction (STEMI) appear to have similar outcomes regardless of whether they undergo a first percutaneous coronary intervention at a center with onsite surgical backup or not, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 16, 2009 Category: Cardiology Source Type: news

A Randomized Comparison of Transradial Versus Transfemoral Approach for Coronary Angiography and AngioplastyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions The findings of the present study show that transradial coronary angiography and angioplasty are safe, feasible, and effective with similar results to those of the transfemoral approach. However, procedural duration and radiation exposure are higher using the transradial access. In contrast to the transfemoral route, the rate of major vascular complications was negligible using the transradial approach. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Brueck, M., Bandorski, D., Kramer, W., Wieczorek, M., Holtgen, R., Tillmanns, H. Tags: Clinical Research Source Type: journals

Mechanism and Predictors of Failed Transradial Approach for Percutaneous Coronary InterventionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Transradial approach PCI can be performed by low-to-intermediate volume operators with standard equipment with a low failure rate. Age >75 years, prior coronary artery bypass graft surgery, and short stature are independent predictors of TR-PCI failure. Appropriate patient selection and careful risk assessment are needed to maximize benefits offered by TR-PCI. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Dehghani, P., Mohammad, A., Bajaj, R., Hong, T., Suen, C. M., Sharieff, W., Chisholm, R. J., Kutryk, M. J.B., Fam, N. P., Cheema, A. N. Tags: Mini-Focus Issue: Transradial Approach Source Type: journals

Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients: Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) RegistryEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Among unselected PCI patients, both post-PCI bleeding and pMI are independently associated with increased 1-year mortality. Continued efforts to reduce these complications after PCI are warranted. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Lindsey, J. B., Marso, S. P., Pencina, M., Stolker, J. M., Kennedy, K. F., Rihal, C., Barsness, G., Piana, R. N., Goldberg, S. L., Cutlip, D. E., Kleiman, N. S., Cohen, D. J., on behalf of the EVENT Registry Investigators Tags: Clinical Research Source Type: journals

Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention: 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) TrialEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions The 1-year mortality rates were low and comparable between patients receiving enoxaparin and UFH during elective PCI. Periprocedural ischemic or bleeding events were the strongest independent predictors of 1-year mortality. (The STEEPLE Trial; NCT00077844) (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Montalescot, G., Gallo, R., White, H. D., Cohen, M., Steg, Ph. G., Aylward, P. E.G., Bode, C., Chiariello, M., King, S. B., Harrington, R. A., Desmet, W. J., Macaya, C., Steinhubl, S. R., for the STEEPLE Investigators Tags: Clinical Research Source Type: journals

Antithrombin Therapy for Elective Percutaneous Coronary Intervention: Which Agent to Use? Does It Matter?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Brener, S. J. Tags: Editorial Comment Source Type: journals

The Worry About Clopidogrel "Nonresponsiveness": Identification and Treatment in the Post-Percutaneous Coronary Intervention PatientEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Gurbel, P. A., Tantry, U. S., Shuldiner, A. R. Tags: Editorial Comment Source Type: journals

Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long-Term Mortality and Left Ventricular Function in Patients After Primary Percutaneous Coronary InterventionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions The presence of a CTO and not MVD alone is associated with long-term mortality even when early deaths are excluded from analysis. The presence of a CTO is associated with reduced LVEF and further deterioration of LVEF. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Claessen, B. E.P.M., van der Schaaf, R. J., Verouden, N. J., Stegenga, N. K., Engstrom, A. E., Sjauw, K. D., Kikkert, W. J., Vis, M. M., Baan, J., Koch, K. T., de Winter, R. J., Tijssen, J. G.P., Piek, J. J., Henriques, J. P.S. Tags: Clinical Research Source Type: journals

No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting StentsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Specific polymorphisms in the chromosome 9p21.3 region that were shown to be associated with coronary heart disease in genomewide analyses were not related to the clinical and angiographic outcomes after the placement of drug-eluting stents in coronary arteries. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Hoppmann, P., Erl, A., Turk, S., Tiroch, K., Mehilli, J., Schomig, A., Kastrati, A., Koch, W. Tags: Clinical Research Source Type: journals

Successful Coronary Angioplasty Via the Radial Approach After Sealing a Radial PerforationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - November 16, 2009 Category: Cardiovascular & Thoracic Surgery Authors: Rigatelli, G., Dell'Avvocata, F., Ronco, F., Doganov, A. Tags: Images in Intervention Source Type: journals

The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic miceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion This study demonstrates that bindarit is effective in reducing neointima formation in both non-hyperlipidaemic and hyperlipidaemic animal models of vascular injury by a direct effect on VSMC proliferation and migration and by reducing neointimal macrophage content. All of these data were associated with the inhibition of MCP-1 production. (Source: Cardiovascular Research)
Source: Cardiovascular Research - November 16, 2009 Category: Cardiology Authors: Grassia, G., Maddaluno, M., Guglielmotti, A., Mangano, G., Biondi, G., Maffia, P., Ialenti, A. Tags: ORIGINAL ARTICLES Source Type: journals

Certain Reflux Drugs Tied to Higher Post-Angioplasty Death RateEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Study suggests interaction between Prilosec, Protonix and blood-thinners such as Plavix Source: HealthDay Related MedlinePlus Topics: Angioplasty, Blood Thinners, GERD (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 16, 2009 Category: Consumer Health News Source Type: consumer

PLATO: Ticagrelor benefits seen in STEMI subanalysisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The investigational oral antiplatelet therapy ticagrelor significantly reduces the risk for major cardiovascular events and all-cause mortality compared with clopidogrel in patients with ST-segment elevation myocardial infarction and planned primary percutaneous coronary intervention, a predefined subanalysis of the PLATO trial shows. (Source: MedWire News - Thrombosis)
Source: MedWire News - Thrombosis - November 16, 2009 Category: Internal Medicine Source Type: news

Mayo Study Shows Stroke Incidence Related to Angioplasty Remains Steady over Past 15 YearsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty remained steady over a 15-year period. (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 16, 2009 Category: Research Authors: Mayo Clinic Source Type: organizations

Mayo Study Shows Stroke Incidence Related to Angioplasty Remains Steady over Past 15 YearsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty remained steady over a 15-year period. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 16, 2009 Category: Databases & Libraries Authors: Mayo Clinic Source Type: organizations

Mayo study shows stroke incidence related to angioplasty remains steady over past 15 yearsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Mayo Clinic) Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty remained steady over a 15-year period. Researchers say this is good news because physicians now are performing the artery-opening procedure on older patients who are sicker and need more complicated treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2009 Category: Global & Universal Source Type: news

PLATO: Ticagrelor benefits seen in STEMI subanalysisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The investigational oral antiplatelet therapy ticagrelor significantly reduces the risk for major cardiovascular events and all-cause mortality compared with clopidogrel in patients with ST-segment elevation myocardial infarction and planned primary percutaneous coronary intervention, a predefined subanalysis of the PLATO trial shows. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - November 16, 2009 Category: Cardiology Source Type: news